ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,048.83
0.03%
Dow Jones
44,730.76
-0.11%
US Dollar vs MXN
20.3329
-0.39%
Brent Oil
73.605
2.39%
Bitcoin
95,653.82
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. ChromaDex Corporation (CDXC) Cotización

ChromaDex Corporation

ChromaDex Corporation (CDXC)

NASDAQ
7.53
-0.03
( -0.40% )
Actualizado: 14:23:25
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
7.53
Postura de Compra
7.53
Postura de Venta
7.54
Volume Operado de la Acción
423,341
7.41 Rango del Día 7.728
1.32 Rango de 52 semanas 7.9738
Capitalización de Mercado [m]
575.166M
Precio Anterior
7.56
Precio de Apertura
7.44
Hora
8
@
7.54
Última hora de negociación
14:23:27
Volumen financiero
US$ 3,206,204
Precio Promedio Ponderado
7.5736
Volumen promedio (3 m)
1,225,517
Acciones en circulación
76,383,267
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-117.03
Beneficio por acción (BPA)
-0.06
turnover
83.57M
Beneficio neto
-4.94M

Acerca de ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. Mostrar más

Sector
Medicinal Chems,botanicl Pds
Industria
Medicinal Chems,botanicl Pds
Sitio web
www.chromadex.com
Sede
Dover, Delaware, USA
Fundado
-
ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker CDXC. The last closing price for ChromaDex was US$7.56. Over the last year, ChromaDex shares have traded in a share price range of US$ 1.32 to US$ 7.9738.

ChromaDex currently has 76,383,267 shares in issue. The market capitalisation of ChromaDex is US$577.46 million. ChromaDex has a price to earnings ratio (PE ratio) of -117.03.

CDXC Últimas noticias

Más noticias

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the...

7 horas hace
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

25 Noviembre 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

21 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

21 Noviembre 2024
Edgar (US Regulatory)

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement ChromaDex Corp. (NASDAQ:...

14 Noviembre 2024
Business Wire

Form 3 - Initial statement of beneficial ownership of securities

08 Noviembre 2024
Edgar (US Regulatory)

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

National rollout provides enhanced accessibility to Niagen IV, a significant advancement in NAD+ IV therapy ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine...

07 Noviembre 2024
Business Wire

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

Total net sales of $25.6 million, up $6.1 million or 31% year-over-year, gross margin of 63.5% and record net income and adjusted EBITDA of $1.9 million and $2.9 million, respectively, for the...

31 Octubre 2024
Business Wire

Form 8-K - Current report

31 Octubre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

31 Octubre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.243.292181069967.297.97387.23016870677.61606428CS
41.933.74777975135.637.97385.5810972577.1154969CS
124.13121.4705882353.47.97383.1612255175.88691361CS
264.77172.8260869572.767.97382.3057768405.0921963CS
526.1426.5734265731.437.97381.325029034.63573941CS
1562.9865.49450549454.557.97381.153442613.32358092CS
2604.03115.1428571433.523.661.155398538.08285229CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ZJKZJK Industrial Company Ltd
US$ 19.20
(202.84%)
25.1M
CTNTCheetah Net Supply Chain Service Inc
US$ 5.1714
(176.55%)
110.92M
GWAVGreenwave Technology Solutions Inc
US$ 0.6778
(85.70%)
486.32M
JYDJayud Global Logistics Ltd
US$ 1.126
(68.03%)
10.08M
JANXJanux Therapeutics Inc
US$ 59.995
(49.32%)
6.49M
REVBRevelation Biosciences Inc
US$ 0.5423
(-42.91%)
4.91M
OMEXOdyssey Marine Exploration Inc
US$ 0.4501
(-39.60%)
3.9M
AGFYAgrify Corporation
US$ 33.25
(-35.66%)
222.5k
STSSSharps Technology Inc
US$ 2.22
(-33.80%)
442.82k
CYCNCyclerion Therapeutics Inc
US$ 1.58
(-32.48%)
328.26k
GWAVGreenwave Technology Solutions Inc
US$ 0.6727
(84.30%)
486.26M
SMCISuper Micro Computer Inc
US$ 40.4191
(-3.76%)
182.04M
NVDANVIDIA Corporation
US$ 139.85
(0.88%)
115.87M
CTNTCheetah Net Supply Chain Service Inc
US$ 5.1714
(176.55%)
109.37M
CHRSCoherus BioSciences Inc
US$ 1.79
(30.66%)
108.76M

CDXC Discussion

Ver más
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXC 7 DOLLA BREAK...BEAST
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
cdxc heres 7 bucks
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXC HERE COMES 7 BUCKS
👍️0
tredenwater2 tredenwater2 4 semanas hace
Amazing how you and your buddies show up here in a similar fashion and are just abead of robust MC increases after years of decline. You must be friends with or connected to HF managers that “get a little loose” after a few drinks.

The stories my brother shared, and others, about this are true.
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXC MONSTER BREAK OUT
👍️0
gail gail 4 semanas hace
congrats!
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXS HEREW W E GO
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXS NEW 52 WEEK HIGH
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
HERE WE GO...BREAKING NEW 52 WEEK HIGH
👍️0
PonkenPlonken PonkenPlonken 4 semanas hace
The GRAS status allows it to be incorporated into conventional foods and beverages.
Most people arent biohacking fanatics.
Ty for mentioning NMN -- ill take a second look.
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
THE NAD SPACE DOES NOT NEED FDA...BUT THIS IS THE ONLY PUBLIC NAD PLAY....NNM NOW BEING ALL THE RAGE!!
👍️0
PonkenPlonken PonkenPlonken 4 semanas hace
The competition is behind as CDXC has FDA safety review = "Generally recognized as safe" (GRAS) status + they have the patents.
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
COMPANY HAS COMPETION NOW IN THE NAD SPACE...SO JUST A TRADE
👍️0
PonkenPlonken PonkenPlonken 4 semanas hace
You are right. If they change the apathic share-selling management that practically - for whatever reason - kept the trial results hidden from the public, this can go far.
Imagine the health and longevity influencers catching on. No media on this for now.
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXC LETS ROLL...COMPANY HAS THE NAD KING!!
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
CDXC HOLDING STRONG
👍️0
gail gail 4 semanas hace
it tried to anyway. lol
👍️0
gail gail 4 semanas hace
nice grab, its moving up now.
👍️0
TrendTrade2016 TrendTrade2016 4 semanas hace
GRABBED THIS DIP....LOVE THIS COMPANY!!!
👍️0
Monksdream Monksdream 1 mes hace
CDXC, new 52=week high
👍️0
Monroe1 Monroe1 1 mes hace
Back in the green. Good company with a great product and huge demand building.
👍️0
Monksdream Monksdream 3 meses hace
CDXC under $4
👍️0
Tiger Money Tiger Money 3 meses hace
I have only added to my position here and plan on selling some at $25
👍️0
Sirpeter Sirpeter 3 meses hace
Good call huh?
👍️0
Tiger Money Tiger Money 4 meses hace
Agreed
👍️0
Sirpeter Sirpeter 4 meses hace
Keep it now...I'm sticking with options in ABT, WDC and UBER...have some HUMA shares too...this will work also...Its in the Russell 2000 will be good with rate cuts...like both
👍️0
Tiger Money Tiger Money 4 meses hace
Haven’t sold yet. U were confident and I’m confident in you!
👍️0
Sirpeter Sirpeter 4 meses hace
Lol
👍️0
Tiger Money Tiger Money 4 meses hace
I bought a bunch of huma yday. It will be a $25-50 stock as soon as the fda pulls its heads out of its asses
👍️0
Sirpeter Sirpeter 4 meses hace
Dumped it...like Huma better
👍️0
Sirpeter Sirpeter 4 meses hace
Still confident this will run soon...don't sell
👍️0
Tiger Money Tiger Money 4 meses hace
I like the plan, thanks
👍️0
Sirpeter Sirpeter 4 meses hace
Not enough improvement in the 2nd qtr to move the needle here yet...will hold it for a week and see what happens
👍️0
Sirpeter Sirpeter 4 meses hace
Fingers crossed
👍️0
Tiger Money Tiger Money 4 meses hace
I don’t plan on selling any ahead of time. I think I have about $4k in this one
👍️0
Sirpeter Sirpeter 4 meses hace
This is a high risk reward play for now...will know tomorrow if got it right
👍️0
Tiger Money Tiger Money 4 meses hace
Thanks! Trying to h to get caught up in this bloodbath
👍️0
Sirpeter Sirpeter 4 meses hace

Gm Tiger
Earnings call here Weds...may not be good this qtr because of the major product roll-out...that's expensive... will still hold this one. not holding much else during this sell off...tech and bio will be good when it's over
👍️0
Tiger Money Tiger Money 4 meses hace
Thanks. Crazy times in the markets!
👍️0
Sirpeter Sirpeter 4 meses hace
Im still holding calls on all these...its a bit early for this one but it will come based on the valuation...most likely in the next qtr...hang in there...in the meantime I've been cleaning up over at ABT...also still waiting on PFE to go...all on positive guidence and Q reports...mkt down today on weak job numbers...its summer what do they expect?
👍️0
Tiger Money Tiger Money 4 meses hace
Why has this been shorting the bed the last two weeks minus today’s market bloodbath? Add more or is it going to keep dropping? Thanks
👍️0
Tiger Money Tiger Money 4 meses hace
Awesome, thanks!
👍️0
Sirpeter Sirpeter 4 meses hace
Eventually about $10...so far I own 30 Nov calls...may add to them
👍️0
Tiger Money Tiger Money 4 meses hace
Thanks! Price target?
👍️0
Sirpeter Sirpeter 4 meses hace
Mass distribution of Niagen a suppliment that helps to extend life...lots of news under the news heading
👍️0
Tiger Money Tiger Money 4 meses hace
Why do you feel so strong about this one? Thanks
👍️0
Tiger Money Tiger Money 4 meses hace
I need to buy a couple thousand shares if I can remember tmrw! Work has been so busy!
👍️0
Sirpeter Sirpeter 4 meses hace
Starting...
👍️0
Sirpeter Sirpeter 4 meses hace
This one is starting...I alerted you
👍️0
Monksdream Monksdream 4 meses hace
CDXC under $3
👍️0

Su Consulta Reciente

NASDAQ
CDXC
ChromaDex
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados